Opinion: FDA Isn’t A Monolith. Engage The Agency Better By Answering These 5 Questions

In this op/ed, former US FDA device compliance chief Steve Silverman argues that savvy manufacturers understand the organizational and operational differences between agency centers and offices. Here, he offers five questions firms should answer before engaging the agency.

5 questions.
• Source: Shutterstock

More from Regulation

More from Policy & Regulation